About Us
Brands in Conversation
Academic Connect
Regional Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Tuesday, June 23, 2026
Sign in / Join
Home
Disclaimer
Facebook
Instagram
Linkedin
Twitter
WhatsApp
About Us
Brands in Conversation
Academic Connect
Regional Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Home
Tags
Zydus Lifesciences
Tag: Zydus Lifesciences
Brands in Conversation
Zydus marks Global Fatty Liver Day with the launch of new public awareness campaign – ‘Liver Ki Suno’
Author
-
June 12, 2026
0
Brands in Conversation
Zydus Therapeutics’ New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA
Author
-
June 1, 2026
0
Brands in Conversation
Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
Author
-
March 18, 2026
0
Brands in Conversation
Zydus and Lupin sign licensing agreement for co-marketing innovative Semaglutide Injection in India
Author
-
March 17, 2026
0
Brands in Conversation
Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry, expanding patient access to GLP-1 therapy
Author
-
February 26, 2026
0
Brands in Conversation
Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
Author
-
December 19, 2025
0
Brands in Conversation
Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
Author
-
December 10, 2025
0
Brands in Conversation
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Passionate in Marketing
-
November 15, 2025
0
Brands in Conversation
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Passionate in Marketing
-
November 14, 2025
0
Brands in Conversation
Zydus’ Amplitude receives CE mark for its robotic surgical system ‘Andy’
Passionate in Marketing
-
November 13, 2025
0
1
2
3
Page 1 of 3